Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xigduo and saxagliptin in drug-naïve type 2 diabetes
NCT02946632Phase 3Unknown
- Sponsor
- Korea University Anam Hospital
- Start
- Dec 2016
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dapagliflozin + metformin, saxagliptin in type 2 diabetes mellitus (T2DM), sponsored by Korea University Anam Hospital. Status: unknown.
02
Drugs
dapagliflozin + metforminsaxagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02946632.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02946632.